{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:04:26Z","timestamp":1794409466748,"version":"4.9.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-025-01059-0","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T11:55:18Z","timestamp":1743767718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["GCN-BBB: Deep Learning Blood-Brain Barrier (BBB) Permeability PharmacoAnalytics with Graph Convolutional Neural (GCN) Network"],"prefix":"10.1208","volume":"27","author":[{"given":"Yankang","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganqian","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maozi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6881-6175","authenticated-orcid":false,"given":"Xiang-Qun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"issue":"1","key":"1059_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The Blood\u2013brain Barrier: Structure, Regulation, and Drug Delivery. Signal Transd Targeted Therapy. 2023;8(1):217. https:\/\/doi.org\/10.1038\/s41392-023-01481-w.","journal-title":"Signal Transd Targeted Therapy"},{"issue":"1","key":"1059_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2045-8118-8-3","volume":"8","author":"Z Redzic","year":"2011","unstructured":"Redzic Z. Molecular Biology of the Blood-brain and the Blood-cerebrospinal Fluid Barriers: Similarities and Differences. Fluids Barr CNS. 2011;8(1):3. https:\/\/doi.org\/10.1186\/2045-8118-8-3.","journal-title":"Fluids Barr CNS"},{"issue":"1","key":"1059_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood-Brain Barrier: From Physiology to Disease and Back. Physiol Rev. 2019;99(1):21\u201378. https:\/\/doi.org\/10.1152\/physrev.00050.2017.","journal-title":"Physiol Rev"},{"issue":"1","key":"1059_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12974-019-1403-x","volume":"16","author":"MA Ma\u0142kiewicz","year":"2019","unstructured":"Ma\u0142kiewicz MA, Szarmach A, Sabisz A, Cuba\u0142a WJ, Szurowska E, Winklewski PJ. Blood-Brain Barrier Permeability and Physical Exercise. J Neuroinflamm. 2019;16(1):15. https:\/\/doi.org\/10.1186\/s12974-019-1403-x.","journal-title":"J Neuroinflamm"},{"key":"1059_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122759","volume":"636","author":"B S\u00e1nchez-Dengra","year":"2023","unstructured":"S\u00e1nchez-Dengra B, Gonz\u00e1lez-\u00c1lvarez I, Bermejo M, Gonz\u00e1lez-\u00c1lvarez M. Access to the CNS: Strategies to Overcome the BBB. Int J Pharm. 2023;636: 122759. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122759.","journal-title":"Int J Pharm"},{"issue":"6","key":"1059_CR6","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/ca.23083","volume":"31","author":"Y Sharif","year":"2018","unstructured":"Sharif Y, Jumah F, Coplan L, Krosser A, Sharif K, Tubbs RS. Blood brain barrier: A Review of Its Anatomy and Physiology in Health and Disease. Clin Anat. 2018;31(6):812\u201323. https:\/\/doi.org\/10.1002\/ca.23083.","journal-title":"Clin Anat"},{"issue":"6","key":"1059_CR7","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.7150\/thno.21254","volume":"8","author":"X Dong","year":"2018","unstructured":"Dong X. Current strategies for brain drug delivery. Theranostics. 2018;8(6):1481\u201393. https:\/\/doi.org\/10.7150\/thno.21254.","journal-title":"Theranostics"},{"issue":"2","key":"1059_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/ijms20020381","volume":"20","author":"KH Wong","year":"2019","unstructured":"Wong KH, Riaz MK, Xie Y, Zhang X, Liu Q, Chen H, et al. Review of Current Strategies for Delivering Alzheimer\u2019s Disease Drugs Across the Blood-brain Barrier. Int J Mol Sci. 2019;20(2):381. https:\/\/doi.org\/10.3390\/ijms20020381.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1059_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/scipharm87010006","volume":"87","author":"LA Bors","year":"2019","unstructured":"Bors LA, Erd\u0151 F. Overcoming the Blood\u2013brain Barrier Challenges and Tricks for CNS drug delivery. Sci Pharm. 2019;87(1):6.","journal-title":"Sci Pharm."},{"issue":"1","key":"1059_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s40001-024-01915-3","volume":"29","author":"I Iqbal","year":"2024","unstructured":"Iqbal I, Saqib F, Mubarak Z, Latif MF, Wahid M, Nasir B, et al. Alzheimer\u2019s Disease and Drug Delivery Across the Blood\u2013brain Barrier: Approaches and Challenges. Eur J Med Res. 2024;29(1):313. https:\/\/doi.org\/10.1186\/s40001-024-01915-3.","journal-title":"Eur J Med Res"},{"key":"1059_CR11","doi-asserted-by":"publisher","first-page":"1394048","DOI":"10.3389\/fonc.2024.1394048","volume":"14","author":"RD Parrondo","year":"2024","unstructured":"Parrondo RD, Ailawadhi S, Cerchione C. Bispecific Antibodies for the Treatment of Relapsed\/refractory Multiple Myeloma: Updates and Future Perspectives. Front Oncol. 2024;14:1394048. https:\/\/doi.org\/10.3389\/fonc.2024.1394048.","journal-title":"Front Oncol"},{"issue":"2","key":"1059_CR12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/leu.2015.229","volume":"30","author":"J Teramachi","year":"2016","unstructured":"Teramachi J, Silbermann R, Yang P, Zhao W, Mohammad KS, Guo J, et al. Blocking the ZZ Domain of Sequestosome1\/p62 sUppresses Myeloma Growth and Osteoclast Formation in Vitro and Induces Dramatic Bone Formation in Myeloma-bearing Bones in Vivo. Leukemia. 2016;30(2):390\u20138. https:\/\/doi.org\/10.1038\/leu.2015.229.","journal-title":"Leukemia"},{"issue":"4","key":"1059_CR13","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.kint.2018.05.023","volume":"94","author":"L Zhou","year":"2018","unstructured":"Zhou L, Zhou S, Yang P, Tian Y, Feng Z, Xie X-Q, et al. Targeted Inhibition of the Type 2 Cannabinoid Receptor is a Novel Approach to Reduce Renal Fibrosis. Kidney Int. 2018;94(4):756\u201372. https:\/\/doi.org\/10.1016\/j.kint.2018.05.023.","journal-title":"Kidney Int"},{"issue":"1","key":"1059_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","volume":"2","author":"W L\u00f6scher","year":"2005","unstructured":"L\u00f6scher W, Potschka H. Blood-brain Barrier Active Efflux Transporters: ATP-Binding Cassette Gene Family. NeuroRx. 2005;2(1):86\u201398. https:\/\/doi.org\/10.1602\/neurorx.2.1.86.","journal-title":"NeuroRx"},{"key":"1059_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.brainresbull.2022.09.017","volume":"190","author":"S Zhang","year":"2022","unstructured":"Zhang S, Gan L, Cao F, Wang H, Gong P, Ma C, et al. The Barrier and Interface Mechanisms of the Brain Barrier, and Brain Drug Delivery. Brain Res Bullet. 2022;190:69\u201383. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.09.017.","journal-title":"Brain Res Bullet"},{"issue":"3","key":"1059_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/s1474-4422(19)30411-9","volume":"19","author":"VL Feigin","year":"2020","unstructured":"Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M, et al. The Global Burden of Neurological Disorders: Translating Evidence Into Policy. Lancet Neurol. 2020;19(3):255\u201365. https:\/\/doi.org\/10.1016\/s1474-4422(19)30411-9.","journal-title":"Lancet Neurol"},{"key":"1059_CR17","unstructured":"Barbarino P. World Alzheimer Report 2024 Global changes in attitudes to dementia. Alzheimer\u2019S Disease International London, England: Alzheimer\u2019s Disease International. 2024."},{"issue":"5","key":"1059_CR18","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1002\/alz.13809","volume":"20","author":"TAS Association","year":"2024","unstructured":"Association TAS. 2024 Alzheimer\u2019s Disease Facts and Figures. Alzheim Dement. 2024;20(5):3708\u2013821. https:\/\/doi.org\/10.1002\/alz.13809.","journal-title":"Alzheim Dement."},{"key":"1059_CR19","unstructured":"(IHME) IfHMaE. GBD Compare data visualization. 2019 [cited 2019 October 8]; Available from: https:\/\/vizhub.healthdata.org\/gbd-compare\/."},{"key":"1059_CR20","doi-asserted-by":"publisher","first-page":"952161","DOI":"10.3389\/fpubh.2022.952161","volume":"10","author":"C Ding","year":"2022","unstructured":"Ding C, Wu Y, Chen X, Chen Y, Wu Z, Lin Z, et al. Global, Regional, and National Burden and Attributable Risk Factors of Neurological Disorders: The Global Burden of Disease study 1990\u20132019. Front Public Health. 2022;10:952161. https:\/\/doi.org\/10.3389\/fpubh.2022.952161.","journal-title":"Front Public Health"},{"issue":"5","key":"1059_CR21","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S1474-4422(19)30029-8","volume":"18","author":"WM Carroll","year":"2019","unstructured":"Carroll WM. The Global Burden of Neurological Disorders. Lancet Neurol. 2019;18(5):418\u20139. https:\/\/doi.org\/10.1016\/S1474-4422(19)30029-8.","journal-title":"Lancet Neurol"},{"key":"1059_CR22","doi-asserted-by":"crossref","unstructured":"BioPharma Dealmakers.\u00a0A view into the central nervous system disorders market.\u00a0Nature NEWS FEATURE:\u00a0Nature; 2020. Available from:\u00a0https:\/\/www.nature.com\/articles\/d43747-020-01119-8.","DOI":"10.1038\/d43747-020-01119-8"},{"key":"1059_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuropharm.2016.03.021","volume":"120","author":"VK Gribkoff","year":"2017","unstructured":"Gribkoff VK, Kaczmarek LK. The Need for New Approaches in CNS Drug Discovery: Why Drugs Have Failed, and What Can Be Done to Improve Outcomes. Neuropharmacology. 2017;120:11\u20139. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.03.021.","journal-title":"Neuropharmacology"},{"issue":"4","key":"1059_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.4155\/ppa.14.22","volume":"3","author":"H Liu","year":"2014","unstructured":"Liu H, Wang L, Su W, Xie XQ. Advances in Recent Patent and Clinical Trial Drug Development for Alzheimer\u2019s disease. Pharm Pat Anal. 2014;3(4):429\u201347. https:\/\/doi.org\/10.4155\/ppa.14.22.","journal-title":"Pharm Pat Anal"},{"issue":"4","key":"1059_CR25","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1021\/ci500004h","volume":"54","author":"H Liu","year":"2014","unstructured":"Liu H, Wang L, Lv M, Pei R, Li P, Pei Z, et al. AlzPlatform: an Alzheimer\u2019s Disease Domain-specific Chemogenomics Knowledgebase for Polypharmacology and Target Identification Research. J Chem Inf Model. 2014;54(4):1050\u201360. https:\/\/doi.org\/10.1021\/ci500004h.","journal-title":"J Chem Inf Model"},{"issue":"1","key":"1059_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3233\/jad-215699","volume":"87","author":"CK Kim","year":"2022","unstructured":"Kim CK, Lee YR, Ong L, Gold M, Kalali A, Sarkar J. Alzheimer\u2019s Disease: Key Insights from Two Decades of Clinical Trial Failures. J Alzheimers Dis. 2022;87(1):83\u2013100. https:\/\/doi.org\/10.3233\/jad-215699.","journal-title":"J Alzheimers Dis"},{"issue":"13","key":"1059_CR27","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.2174\/1381612826666200224112534","volume":"26","author":"Y Morofuji","year":"2020","unstructured":"Morofuji Y, Nakagawa S. Drug Development for Central Nervous System Diseases Using in Vitro Blood-brain Barrier Models and Drug Repositioning. Curr Pharm Des. 2020;26(13):1466\u201385. https:\/\/doi.org\/10.2174\/1381612826666200224112534.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"1059_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"Pardridge WM. The blood-brain barrier: Bottleneck in brain drug development. NeuroRx. 2005;2(1):3\u201314. https:\/\/doi.org\/10.1602\/neurorx.2.1.3.","journal-title":"NeuroRx"},{"issue":"1","key":"1059_CR29","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1471-2377-9-S1-S3","volume":"9","author":"WA Banks","year":"2009","unstructured":"Banks WA. Characteristics of Compounds That Cross the Blood-brain Barrier. BMC Neurol. 2009;9(1):S3. https:\/\/doi.org\/10.1186\/1471-2377-9-S1-S3.","journal-title":"BMC Neurol"},{"key":"1059_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3389\/fnins.2020.00513","volume":"14","author":"E Pimentel","year":"2020","unstructured":"Pimentel E, Sivalingam K, Doke M, Samikkannu T. Effects of Drugs of Abuse On the Blood-brain Barrier: a Brief Overview. Front Neurosci. 2020;14:513. https:\/\/doi.org\/10.3389\/fnins.2020.00513.","journal-title":"Front Neurosci."},{"issue":"4","key":"1059_CR31","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2020.01.007","volume":"180","author":"C Xing","year":"2020","unstructured":"Xing C, Zhuang Y, Xu T-H, Feng Z, Zhou XE, Chen M, et al. Cryo-EM Structure of the Human Cannabinoid Receptor CB2-Gi Signaling Complex. Cell (Cambridge, MA, U S). 2020;180(4):645-54.e13. https:\/\/doi.org\/10.1016\/j.cell.2020.01.007.","journal-title":"Cell (Cambridge, MA, U S)"},{"issue":"2","key":"1059_CR32","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.kint.2020.09.025","volume":"99","author":"S Zhou","year":"2021","unstructured":"Zhou S, Wu Q, Lin X, Ling X, Miao J, Liu X, et al. Cannabinoid receptor type 2 promotes kidney fibrosis through orchestrating \u03b2-catenin signaling. Kidney Int. 2021;99(2):364\u201381. https:\/\/doi.org\/10.1016\/j.kint.2020.09.025.","journal-title":"Kidney Int"},{"issue":"5","key":"1059_CR33","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1111\/jcmm.16128","volume":"25","author":"F Tian","year":"2021","unstructured":"Tian F, Yang H-T, Huang T, Chen F-F, Xiong F-J. Involvement of CB2 Signalling Pathway in the Development of Osteoporosis By Regulating the Proliferation and Differentiation of hBMSCs. J Cell Mol Med. 2021;25(5):2426\u201335. https:\/\/doi.org\/10.1111\/jcmm.16128.","journal-title":"J Cell Mol Med."},{"issue":"22","key":"1059_CR34","doi-asserted-by":"publisher","first-page":"9973","DOI":"10.1021\/jm301212u","volume":"55","author":"P Yang","year":"2012","unstructured":"Yang P, Myint K-Z, Tong Q, Feng R, Cao H, Almehizia AA, et al. Lead Discovery, Chemistry Optimization, and Biological Evaluation Studies of Novel Biamide Derivatives as cb2 Receptor Inverse Agonists and Osteoclast Inhibitors. J Med Chem. 2012;55(22):9973\u201387. https:\/\/doi.org\/10.1021\/jm301212u.","journal-title":"J Med Chem"},{"issue":"23","key":"1059_CR35","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","volume":"73","author":"C Turcotte","year":"2016","unstructured":"Turcotte C, Blanchet M-R, Laviolette M, Flamand N. The CB2 Receptor and Its Role As a Regulator of Inflammation. Cell Mol Life Sci. 2016;73(23):4449\u201370. https:\/\/doi.org\/10.1007\/s00018-016-2300-4.","journal-title":"Cell Mol Life Sci"},{"key":"1059_CR36","doi-asserted-by":"publisher","first-page":"106560","DOI":"10.1016\/j.phrs.2022.106560","volume":"187","author":"LM Carey","year":"2023","unstructured":"Carey LM, Xu Z, Rajic G, Makriyannis A, Romero J, Hillard C, et al. Peripheral Sensory Neuron CB2 Cannabinoid Receptors Are Necessary for Both CB2-mediated Antinociceptive Efficacy and Sparing of Morphine Tolerance in a Mouse Model of Anti-retroviral Toxic Neuropathy. Pharmacol Res. 2023;187:106560. https:\/\/doi.org\/10.1016\/j.phrs.2022.106560.","journal-title":"Pharmacol Res"},{"issue":"3","key":"1059_CR37","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/pharmaceutics12030265","volume":"12","author":"F Calapai","year":"2020","unstructured":"Calapai F, Cardia L, Sorbara EE, Navarra M, Gangemi S, Calapai G, et al. Cannabinoids, Blood-brain Barrier, and Brain Disposition. Pharmaceutics. 2020;12(3):265. https:\/\/doi.org\/10.3390\/pharmaceutics12030265.","journal-title":"Pharmaceutics"},{"key":"1059_CR38","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.2147\/DDDT.S218708","volume":"13","author":"S Bagchi","year":"2019","unstructured":"Bagchi S, Chhibber T, Lahooti B, Verma A, Borse V, Jayant RD. In-Vitro Blood-brain Barrier Models for Drug Screening and Permeation Studies: an Overview. Drug Des Dev Ther. 2019;13:3591\u2013605. https:\/\/doi.org\/10.2147\/DDDT.S218708.","journal-title":"Drug Des Dev Ther"},{"issue":"1","key":"1059_CR39","first-page":"115","volume":"12","author":"M Vastag","year":"2009","unstructured":"Vastag M, Keseru GM. Current in Vitro and in Silico Models of Blood-brain Barrier Penetration: a Practical View. Curr Opin Drug Discov Devel. 2009;12(1):115\u201324.","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"6","key":"1059_CR40","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1021\/cr60274a001","volume":"71","author":"A Leo","year":"1971","unstructured":"Leo A, Hansch C, Elkins D. Partition Coefficients and Their Uses. Chem Rev. 1971;71(6):525\u2013616. https:\/\/doi.org\/10.1021\/cr60274a001.","journal-title":"Chem Rev"},{"issue":"13","key":"1059_CR41","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1021\/jm060230+","volume":"49","author":"G Ottaviani","year":"2006","unstructured":"Ottaviani G, Martel S, Carrupt P-A. Parallel Artificial Membrane Permeability Assay: a New Membrane for the Fast Prediction of Passive Human Skin Permeability. J Med Chem. 2006;49(13):3948\u201354. https:\/\/doi.org\/10.1021\/jm060230+.","journal-title":"J Med Chem"},{"key":"1059_CR42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/B978-012369520-8.50029-2","volume-title":"Drug-like Properties: Concepts, Structure Design and Methods","author":"EH Kerns","year":"2008","unstructured":"Kerns EH, Di L. Chapter 28 - Blood-Brain Barrier Methods. In: Kerns EH, Di L, editors. Drug-like Properties: Concepts, Structure Design and Methods. San Diego: Academic Press; 2008. p. 311\u201328."},{"issue":"5","key":"1059_CR43","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/pharmaceutics16050574","volume":"16","author":"JY Yang","year":"2024","unstructured":"Yang JY, Shin DS, Jeong M, Kim SS, Jeong HN, Lee BH, et al. Evaluation of Drug Blood-brain-barrier Permeability Using a Microfluidic Chip. Pharmaceutics. 2024;16(5):574. https:\/\/doi.org\/10.3390\/pharmaceutics16050574.","journal-title":"Pharmaceutics"},{"issue":"6","key":"1059_CR44","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/cn100008c","volume":"1","author":"TT Wager","year":"2010","unstructured":"Wager TT, Hou X, Verhoest PR, Villalobos A. Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) approach to enable alignment of druglike properties. ACS Chem Neurosci. 2010;1(6):435\u201349. https:\/\/doi.org\/10.1021\/cn100008c.","journal-title":"ACS Chem Neurosci"},{"issue":"6","key":"1059_CR45","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1021\/ci000065l","volume":"40","author":"T \u00d6sterberg","year":"2000","unstructured":"\u00d6sterberg T, Norinder U. Prediction of Polar Surface Area and Drug Transport Processes Using Simple Parameters and PLS Statistics. J Chem Inf Comput Sci. 2000;40(6):1408\u201311. https:\/\/doi.org\/10.1021\/ci000065l.","journal-title":"J Chem Inf Comput Sci"},{"issue":"2","key":"1059_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/10611869808997889","volume":"6","author":"H van de Waterbeemd","year":"1998","unstructured":"van de Waterbeemd H, Camenisch G, Folkers G, Chretien JR, Raevsky OA. Estimation of Blood-brain Barrier Crossing of Drugs Using Molecular Size and Shape, and H-bonding Descriptors. J Drug Target. 1998;6(2):151\u201365. https:\/\/doi.org\/10.3109\/10611869808997889.","journal-title":"J Drug Target"},{"issue":"10","key":"1059_CR47","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1023\/a:1015040217741","volume":"16","author":"J Kelder","year":"1999","unstructured":"Kelder J, Grootenhuis PD, Bayada DM, Delbressine LP, Ploemen JP. Polar Molecular Surface As a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs. Pharm Res. 1999;16(10):1514\u20139. https:\/\/doi.org\/10.1023\/a:1015040217741.","journal-title":"Pharm Res"},{"issue":"2","key":"1059_CR48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/md17020081","volume":"17","author":"F Plisson","year":"2019","unstructured":"Plisson F, Piggott AM. Predicting Blood\u207bbrain Barrier Permeability of Marine-derived Kinase Inhibitors Using Ensemble Classifiers Reveals Potential Hits for Neurodegenerative Disorders. Mar Drugs. 2019;17(2):81. https:\/\/doi.org\/10.3390\/md17020081.","journal-title":"Mar Drugs"},{"issue":"6","key":"1059_CR49","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1021\/acs.molpharmaceut.9b00182","volume":"16","author":"Y Bian","year":"2019","unstructured":"Bian Y, Jing Y, Wang L, Ma S, Jun JJ, Xie X-Q. Prediction of Orthosteric and Allosteric Regulations On Cannabinoid Receptors Using Supervised Machine Learning Classifiers. Mol Pharm. 2019;16(6):2605\u201315. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00182.","journal-title":"Mol Pharm"},{"issue":"6","key":"1059_CR50","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/biom11060870","volume":"11","author":"T Hou","year":"2021","unstructured":"Hou T, Bian Y, McGuire T, Xie X-Q. Integrated Multi-class Classification and Prediction of Gpcr Allosteric Modulators By Machine Learning Intelligence. Biomolecules. 2021;11(6):870.","journal-title":"Biomolecules"},{"key":"1059_CR51","doi-asserted-by":"publisher","first-page":"107604","DOI":"10.1016\/j.drugalcdep.2019.107604","volume":"206","author":"Z Hu","year":"2020","unstructured":"Hu Z, Jing Y, Xue Y, Fan P, Wang L, Vanyukov M, et al. Analysis of Substance Use and Its Outcomes By Machine Learning: II. Derivation and Prediction of the Trajectory of Substance Use Severity. Drug Alcohol Depend. 2020;206:107604. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107604.","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"1059_CR52","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1208\/s12248-018-0210-0","volume":"20","author":"Y Jing","year":"2018","unstructured":"Jing Y, Bian Y, Hu Z, Wang L, Xie XQ. Deep Learning for Drug Design: an Artificial Intelligence Paradigm for Drug Discovery in the Big Data Era. Aaps J. 2018;20(3):58. https:\/\/doi.org\/10.1208\/s12248-018-0210-0.","journal-title":"Aaps J"},{"key":"1059_CR53","doi-asserted-by":"publisher","first-page":"107605","DOI":"10.1016\/j.drugalcdep.2019.107605","volume":"206","author":"Y Jing","year":"2020","unstructured":"Jing Y, Hu Z, Fan P, Xue Y, Wang L, Tarter RE, et al. Analysis of Substance Use and Its Outcomes By Machine Learning I. Childhood Evaluation of Liability to Substance Use Disorder. Drug Alcohol Depend. 2020;206:107605. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107605.","journal-title":"Drug Alcohol Depend."},{"key":"1059_CR54","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/978-981-99-1284-1_32","volume-title":"The Quintessence of Basic and Clinical Research and Scientific Publishing","author":"G Zhao","year":"2023","unstructured":"Zhao G, Zhao S, Xie X-Q. Artificial Intelligence Technologies for Clinical Data PharmacoAnalytics Case Studies on Alzheimer\u2019s Disease. In: Jagadeesh G, Balakumar P, Senatore F, editors. The Quintessence of Basic and Clinical Research and Scientific Publishing. Singapore: Springer Nature Singapore; 2023. p. 523\u201338."},{"issue":"1","key":"1059_CR55","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13321-022-00619-2","volume":"14","author":"X Tong","year":"2022","unstructured":"Tong X, Wang D, Ding X, Tan X, Ren Q, Chen G, et al. Blood\u2013Brain Barrier Penetration Prediction Enhanced By Uncertainty Estimation. J Cheminform. 2022;14(1):44. https:\/\/doi.org\/10.1186\/s13321-022-00619-2.","journal-title":"J Cheminform"},{"issue":"8","key":"1059_CR56","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1007\/s11095-008-9609-0","volume":"25","author":"L Zhang","year":"2008","unstructured":"Zhang L, Zhu H, Oprea TI, Golbraikh A, Tropsha A. QSAR Modeling of the Blood-brain Barrier Permeability for Diverse Organic Compounds. Pharm Res. 2008;25(8):1902\u201314. https:\/\/doi.org\/10.1007\/s11095-008-9609-0.","journal-title":"Pharm Res"},{"issue":"1","key":"1059_CR57","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13321-023-00773-1","volume":"15","author":"A Naseem","year":"2023","unstructured":"Naseem A, Alturise F, Alkhalifah T, Khan YD. BBB-PEP-prediction: Improved Computational Model for Identification of Blood\u2013brain Barrier Peptides Using Blending Position Relative Composition Specific Features and Ensemble Modeling. J Cheminformat. 2023;15(1):110. https:\/\/doi.org\/10.1186\/s13321-023-00773-1.","journal-title":"J Cheminformat"},{"issue":"10","key":"1059_CR58","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.1021\/acs.jcim.4c00433","volume":"64","author":"V Kumar","year":"2024","unstructured":"Kumar V, Banerjee A, Roy K. Breaking the Barriers: Machine-learning-based C-rasar Approach for Accurate Blood-brain Barrier Permeability Prediction. J Chem Inf Model. 2024;64(10):4298\u2013309. https:\/\/doi.org\/10.1021\/acs.jcim.4c00433.","journal-title":"J Chem Inf Model"},{"key":"1059_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.106984","volume":"160","author":"B Mazumdar","year":"2023","unstructured":"Mazumdar B, Deva Sarma PK, Mahanta HJ, Sastry GN. Machine Learning Based Dynamic Consensus Model for Predicting Blood-brain Barrier Permeability. Comput Biol Med. 2023;160: 106984. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106984.","journal-title":"Comput Biol Med"},{"issue":"10","key":"1059_CR60","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/bioinformatics\/btad577","volume":"39","author":"B Shaker","year":"2023","unstructured":"Shaker B, Lee J, Lee Y, Yu M-S, Lee H-M, Lee E, et al. A Machine Learning-based Quantitative Model (LogBB_Pred) to Predict the Blood\u2013brain Barrier Permeability (logBB value) of Drug Compounds. Bioinformatics. 2023;39(10):577. https:\/\/doi.org\/10.1093\/bioinformatics\/btad577.","journal-title":"Bioinformatics."},{"issue":"17","key":"1059_CR61","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1021\/acs.jcim.3c00768","volume":"63","author":"L Storchi","year":"2023","unstructured":"Storchi L, Cruciani G, Cross S. DeepGRID: Deep Learning Using GRID Descriptors for BBB Prediction. J Chem Inf Model. 2023;63(17):5496\u2013512. https:\/\/doi.org\/10.1021\/acs.jcim.3c00768.","journal-title":"J Chem Inf Model"},{"key":"1059_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2019.107516","volume":"96","author":"M Singh","year":"2020","unstructured":"Singh M, Divakaran R, Konda LSK, Kristam R. A Classification Model for Blood Brain Barrier Penetration. J Mol Graph Model. 2020;96: 107516. https:\/\/doi.org\/10.1016\/j.jmgm.2019.107516.","journal-title":"J Mol Graph Model"},{"issue":"2","key":"1059_CR63","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11030-016-9715-6","volume":"21","author":"K Lingineni","year":"2017","unstructured":"Lingineni K, Belekar V, Tangadpalliwar SR, Garg P. The role of multidrug resistance protein (MRP-1) as an active efflux transporter on blood-brain barrier (BBB) permeability. Mol Divers. 2017;21(2):355\u201365. https:\/\/doi.org\/10.1007\/s11030-016-9715-6.","journal-title":"Mol Divers"},{"key":"1059_CR64","first-page":"16","volume":"1","author":"S Kunwittaya","year":"2013","unstructured":"Kunwittaya S, Nantasenamat C, Treeratanapiboon L, Srisarin A, Isarankura-Na-Ayudhya C, Prachayasittikul V. Influence of logBB Cut-off On the Prediction of Blood-brain Barrier Permeability. Biomed Appl Technol J. 2013;1:16\u201334.","journal-title":"Biomed Appl Technol J"},{"issue":"8","key":"1059_CR65","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1007\/s11095-008-9584-5","volume":"25","author":"S Kortagere","year":"2008","unstructured":"Kortagere S, Chekmarev D, Welsh WJ, Ekins S. New Predictive Models for Blood\u2013brain Barrier Permeability of Drug-like Molecules. Pharm Res. 2008;25(8):1836\u201345.","journal-title":"Pharm Res"},{"issue":"16","key":"1059_CR66","doi-asserted-by":"publisher","first-page":"16774","DOI":"10.1021\/acsomega.9b01512","volume":"4","author":"D Roy","year":"2019","unstructured":"Roy D, Hinge VK, Kovalenko A. To Pass or Not to Pass: Predicting the Blood-brain Barrier Permeability With the 3D-RISM-KH Molecular Solvation Theory. ACS Omega. 2019;4(16):16774\u201380. https:\/\/doi.org\/10.1021\/acsomega.9b01512.","journal-title":"ACS Omega"},{"issue":"20","key":"1059_CR67","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1002\/cmdc.201800533","volume":"13","author":"Z Wang","year":"2018","unstructured":"Wang Z, Yang H, Wu Z, Wang T, Li W, Tang Y, et al. In Silico Prediction of Blood-brain Barrier Permeability of Compounds By Machine Learning and Resampling Methods. ChemMedChem. 2018;13(20):2189\u2013201. https:\/\/doi.org\/10.1002\/cmdc.201800533.","journal-title":"ChemMedChem"},{"issue":"3","key":"1059_CR68","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1208\/s12248-018-0215-8","volume":"20","author":"Y Yuan","year":"2018","unstructured":"Yuan Y, Zheng F, Zhan CG. Improved Prediction of Blood-brain Barrier Permeability Through Machine Learning With Combined Use of Molecular Property-based Descriptors and Fingerprints. Aaps j. 2018;20(3):54. https:\/\/doi.org\/10.1208\/s12248-018-0215-8.","journal-title":"Aaps j"},{"issue":"5","key":"1059_CR69","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1021\/acs.molpharmaceut.6b00031","volume":"13","author":"YY Zhang","year":"2016","unstructured":"Zhang YY, Liu H, Summerfield SG, Luscombe CN, Sahi J. Integrating in Silico and in Vitro Approaches to Predict Drug Accessibility to the Central Nervous System. Mol Pharm. 2016;13(5):1540\u201350. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00031.","journal-title":"Mol Pharm"},{"issue":"1","key":"1059_CR70","doi-asserted-by":"publisher","first-page":"8802","DOI":"10.1038\/s41598-019-44773-4","volume":"9","author":"R Miao","year":"2019","unstructured":"Miao R, Xia L-Y, Chen H-H, Huang H-H, Liang Y. Improved Classification of Blood-brain-barrier Drugs Using Deep Learning. Sci Rep. 2019;9(1):8802. https:\/\/doi.org\/10.1038\/s41598-019-44773-4.","journal-title":"Sci Rep"},{"issue":"5","key":"1059_CR71","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3390\/cells11050915","volume":"11","author":"Y Bian","year":"2022","unstructured":"Bian Y, Xie XQ. Artificial Intelligent Deep Learning Molecular Generative Modeling of Scaffold-focused and Cannabinoid CB2 Target-specific Small-molecule Sublibraries. Cells. 2022;11(5):915. https:\/\/doi.org\/10.3390\/cells11050915.","journal-title":"Cells"},{"key":"1059_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.858126","volume":"16","author":"R Kumar","year":"2022","unstructured":"Kumar R, Sharma A, Alexiou A, Bilgrami AL, Kamal MA, Ashraf GM. DeePred-BBB: A Blood Brain Barrier Permeability Prediction Model With Improved Accuracy. Front Neurosci. 2022;16: 858126. https:\/\/doi.org\/10.3389\/fnins.2022.858126.","journal-title":"Front Neurosci"},{"issue":"8","key":"1059_CR73","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/bioinformatics\/btaa918","volume":"37","author":"B Shaker","year":"2020","unstructured":"Shaker B, Yu M-S, Song JS, Ahn S, Ryu JY, Oh K-S, et al. LightBBB: Computational Prediction Model of Blood\u2013brain-barrier Penetration Based on LightGBM. Bioinformatics. 2020;37(8):1135\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa918.","journal-title":"Bioinformatics"},{"key":"1059_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2020.107377","volume":"89","author":"S Alsenan","year":"2020","unstructured":"Alsenan S, Al-Turaiki I, Hafez A. A Recurrent Neural Network Model to Predict Blood-brain Barrier Permeability. Comput Biol Chem. 2020;89: 107377. https:\/\/doi.org\/10.1016\/j.compbiolchem.2020.107377.","journal-title":"Comput Biol Chem"},{"key":"1059_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2020.107377","volume":"89","author":"S Alsenan","year":"2020","unstructured":"Alsenan S, Al-Turaiki I, Hafez A. A rEcurrent Neural Network Model to Predict Blood\u2013brain Barrier Permeability. Comput Biol Chem. 2020;89: 107377.","journal-title":"Comput Biol Chem"},{"key":"1059_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2023.102538","volume":"79","author":"P Veli\u010dkovi\u0107","year":"2023","unstructured":"Veli\u010dkovi\u0107 P. Everything is connected: Graph neural networks. Curr Opin Struct Biol. 2023;79: 102538. https:\/\/doi.org\/10.1016\/j.sbi.2023.102538.","journal-title":"Curr Opin Struct Biol"},{"key":"1059_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.690049","volume":"12","author":"XM Zhang","year":"2021","unstructured":"Zhang XM, Liang L, Liu L, Tang MJ. Graph Neural Networks and Their Current Applications in Bioinformatics. Front Genet. 2021;12: 690049. https:\/\/doi.org\/10.3389\/fgene.2021.690049.","journal-title":"Front Genet"},{"issue":"6","key":"1059_CR78","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/bib\/bbac408","volume":"23","author":"H Cai","year":"2022","unstructured":"Cai H, Zhang H, Zhao D, Wu J, Wang L. FP-GNN: A Versatile Deep Learning Architecture for Enhanced Molecular Property Prediction. Brief Bioinform. 2022;23(6):408. https:\/\/doi.org\/10.1093\/bib\/bbac408.","journal-title":"Brief Bioinform"},{"key":"1059_CR79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.aiopen.2021.01.001","volume":"1","author":"J Zhou","year":"2020","unstructured":"Zhou J, Cui G, Hu S, Zhang Z, Yang C, Liu Z, et al. Graph Neural Networks: A Review of Methods and Applications. AI Open. 2020;1:57\u201381. https:\/\/doi.org\/10.1016\/j.aiopen.2021.01.001.","journal-title":"AI Open"},{"issue":"7","key":"1059_CR80","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.1007\/s10462-022-10306-1","volume":"56","author":"H Askr","year":"2023","unstructured":"Askr H, Elgeldawi E, Aboul Ella H, Elshaier YAMM, Gomaa MM, Hassanien AE. Deep Learning in Drug Discovery: an Integrative Review and Future Challenges. Artif Intell Rev. 2023;56(7):5975\u20136037. https:\/\/doi.org\/10.1007\/s10462-022-10306-1.","journal-title":"Artif Intell Rev"},{"issue":"3","key":"1059_CR81","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/bib\/bbz042","volume":"21","author":"M Sun","year":"2019","unstructured":"Sun M, Zhao S, Gilvary C, Elemento O, Zhou J, Wang F. Graph Convolutional Networks for Computational Drug Development and Discovery. Brief Bioinformat. 2019;21(3):919\u201335. https:\/\/doi.org\/10.1093\/bib\/bbz042.","journal-title":"Brief Bioinformat"},{"issue":"1","key":"1059_CR82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13321-020-00479-8","volume":"13","author":"D Jiang","year":"2021","unstructured":"Jiang D, Wu Z, Hsieh C-Y, Chen G, Liao B, Wang Z, et al. Could Graph Neural Networks Learn Better Molecular Representation for Drug Discovery? A Comparison Study of Descriptor-based and Graph-based Models. J Cheminformat. 2021;13(1):12. https:\/\/doi.org\/10.1186\/s13321-020-00479-8.","journal-title":"J Cheminformat"},{"issue":"1","key":"1059_CR83","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1021\/ci034205d","volume":"44","author":"M Adenot","year":"2004","unstructured":"Adenot M, Lahana R. Blood-brain barrier permeation models: discriminating between potential CNS and non-CNS drugs including P-glycoprotein substrates. J Chem Inf Comput Sci. 2004;44(1):239\u201348. https:\/\/doi.org\/10.1021\/ci034205d.","journal-title":"J Chem Inf Comput Sci"},{"issue":"5","key":"1059_CR84","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1021\/ci050135u","volume":"45","author":"H Li","year":"2005","unstructured":"Li H, Yap CW, Ung CY, Xue Y, Cao ZW, Chen YZ. Effect of sElection of Molecular Descriptors On the Prediction of Blood-brain Barrier Penetrating and Nonpenetrating Agents By Statistical Learning Methods. J Chem Inf Model. 2005;45(5):1376\u201384. https:\/\/doi.org\/10.1021\/ci050135u.","journal-title":"J Chem Inf Model"},{"issue":"1","key":"1059_CR85","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1021\/ci600312d","volume":"47","author":"YH Zhao","year":"2007","unstructured":"Zhao YH, Abraham MH, Ibrahim A, Fish PV, Cole S, Lewis ML, et al. Predicting Penetration Across the Blood-brain Barrier From Simple Descriptors and Fragmentation Schemes. J Chem Inf Model. 2007;47(1):170\u20135. https:\/\/doi.org\/10.1021\/ci600312d.","journal-title":"J Chem Inf Model"},{"issue":"5","key":"1059_CR86","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1021\/ci050135u","volume":"45","author":"H Li","year":"2005","unstructured":"Li H, Yap CW, Ung CY, Xue Y, Cao ZW, Chen YZ. Effect of sElection of Molecular Descriptors On the Prediction of Blood\u2212 Brain Barrier Penetrating and Nonpenetrating Agents By Statistical Learning Methods. J Chem Inf Model. 2005;45(5):1376\u201384.","journal-title":"J Chem Inf Model"},{"key":"1059_CR87","unstructured":"Landrum G. RDKit: A Software Suite for Cheminformatics, Computational Chemistry, and Predictive Modeling. Academic Press; 2013."},{"key":"1059_CR88","unstructured":"Release S. 2: LigPrep, Schr\u00f6dinger, LLC, New York, NY, 2017. New York, NY. 2017."},{"key":"1059_CR89","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ymeth.2014.08.005","volume":"71","author":"A Cereto-Massagu\u00e9","year":"2015","unstructured":"Cereto-Massagu\u00e9 A, Ojeda MJ, Valls C, Mulero M, Garcia-Vallv\u00e9 S, Pujadas G. Molecular fIngerprint Similarity Search in Virtual Screening. Methods. 2015;71:58\u201363. https:\/\/doi.org\/10.1016\/j.ymeth.2014.08.005.","journal-title":"Methods"},{"issue":"11","key":"1059_CR90","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1021\/acs.molpharmaceut.9b00500","volume":"16","author":"Y Bian","year":"2019","unstructured":"Bian Y, Wang J, Jun JJ, Xie X-Q. Deep Convolutional Generative Adversarial Network (dcGAN) models for screening and design of small molecules targeting cannabinoid receptors. Mol Pharm. 2019;16(11):4451\u201360. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00500.","journal-title":"Mol Pharm"},{"issue":"3","key":"1059_CR91","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1021\/ci700193u","volume":"48","author":"X-Q Xie","year":"2008","unstructured":"Xie X-Q, Chen J-Z. Data mining a Small Molecule Drug Screening Representative Subset from NIH PubChem. J Chem Inf Model. 2008;48(3):465\u201375. https:\/\/doi.org\/10.1021\/ci700193u.","journal-title":"J Chem Inf Model"},{"issue":"12","key":"1059_CR92","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1517\/17460441.2010.524924","volume":"5","author":"X-Q Xie","year":"2010","unstructured":"Xie X-Q. Exploiting PubChem for Virtual Screening. Expert Opin Drug Discov. 2010;5(12):1205\u201320.","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"1059_CR93","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13321-014-0051-5","volume":"7","author":"M Awale","year":"2015","unstructured":"Awale M, Jin X, Reymond J-L. Stereoselective Virtual Screening of the ZINC Database Using Atom Pair 3D-fingerprints. J Cheminformat. 2015;7(1):3. https:\/\/doi.org\/10.1186\/s13321-014-0051-5.","journal-title":"J Cheminformat."},{"issue":"2","key":"1059_CR94","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","volume":"25","author":"J Wang","year":"2006","unstructured":"Wang J, Wang W, Kollman PA, Case DA. Automatic Atom Type and Bond Type Perception in Molecular Mechanical Calculations. J Mol Graph Model. 2006;25(2):247\u201360. https:\/\/doi.org\/10.1016\/j.jmgm.2005.12.005.","journal-title":"J Mol Graph Model"},{"key":"1059_CR95","first-page":"2541","volume":"7","author":"P Zhao","year":"2006","unstructured":"Zhao P, Yu B. On Model Selection Consistency of Lasso. J Mach Learn Res. 2006;7:2541\u201363.","journal-title":"J Mach Learn Res"},{"key":"1059_CR96","doi-asserted-by":"crossref","unstructured":"Kenter T, Borisov A, De Rijke M. Siamese cbow: Optimizing Word Embeddings for Sentence Representations. arXiv preprint arXiv:160604640. 2016.","DOI":"10.18653\/v1\/P16-1089"},{"issue":"11","key":"1059_CR97","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling T, Irwin JJ. ZINC 15 \u2013 Ligand Discovery for Everyone. J Chem Inf Model. 2015;55(11):2324\u201337. https:\/\/doi.org\/10.1021\/acs.jcim.5b00559.","journal-title":"J Chem Inf Model"},{"key":"1059_CR98","unstructured":"Abadi M, Barham P, Chen J, Chen Z, Davis A, Dean J, et al., editors. Tensorflow: A system for large-scale machine learning. 12th USENIX symposium on operating systems design and implementation (OSDI); 2016."},{"issue":"1","key":"1059_CR99","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random forests. Mach Learn. 2001;45(1):5\u201332.","journal-title":"Mach Learn"},{"key":"1059_CR100","unstructured":"Soman K, Loganathan R, Ajay V. Machine learning with SVM and other kernel methods: PHI Learning Pvt. Ltd.; 2009."},{"key":"1059_CR101","unstructured":"Solomatine DP, Shrestha DL, editors. AdaBoost. RT: a boosting algorithm for regression problems. 2004 IEEE Int Joint Conf Neur Netw (IEEE Cat No 04CH37541); 2004 IEEE."},{"key":"1059_CR102","unstructured":"Rish I, editor. An empirical study of the naive Bayes classifier. IJCAI 2001 Workshop Empiric Methods Artif Intell; 2001."},{"key":"1059_CR103","unstructured":"Kleinbaum DG, Dietz K, Gail M, Klein M, Klein M. Logistic regression: Springer; 2002."},{"issue":"14\u201315","key":"1059_CR104","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1016\/S1352-2310(97)00447-0","volume":"32","author":"MW Gardner","year":"1998","unstructured":"Gardner MW, Dorling S. Artificial neural networks (the multilayer perceptron)\u2014a review of applications in the atmospheric sciences. Atmospher Environ. 1998;32(14\u201315):2627\u201336.","journal-title":"Atmospher Environ"},{"key":"1059_CR105","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: Machine Learning in Python. J Mach Learn Res. 2011;12:2825\u201330.","journal-title":"J Mach Learn Res"},{"issue":"20","key":"1059_CR106","doi-asserted-by":"publisher","first-page":"5228","DOI":"10.1021\/acs.jpcb.7b02914","volume":"121","author":"BJ Bennion","year":"2017","unstructured":"Bennion BJ, Be NA, McNerney MW, Lao V, Carlson EM, Valdez CA, et al. Predicting a Drug\u2019s Membrane Permeability: a Computational Model Validated With in Vitro Permeability Assay Data. J Phys Chem B. 2017;121(20):5228\u201337. https:\/\/doi.org\/10.1021\/acs.jpcb.7b02914.","journal-title":"J Phys Chem B"},{"key":"1059_CR107","doi-asserted-by":"crossref","unstructured":"Sahbi H. Learning Laplacians in Chebyshev Graph Convolutional Networks. 2021 IEEE\/CVF International Conference on Computer Vision Workshops (ICCVW)2021;2064\u201375.","DOI":"10.1109\/ICCVW54120.2021.00234"},{"key":"1059_CR108","doi-asserted-by":"crossref","unstructured":"Wang Y, Li Z, Barati Farimani A. Graph nEural Networks for Molecules. Machine Learning in Molecular Sciences: Springer; 2023;21\u201366.","DOI":"10.1007\/978-3-031-37196-7_2"},{"issue":"9","key":"1059_CR109","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00044-024-03260-w","volume":"33","author":"S Atasever","year":"2024","unstructured":"Atasever S. In Silico Drug Discovery: a Machine Learning-driven Systematic Review. Med Chem Res. 2024;33(9):1465\u201390. https:\/\/doi.org\/10.1007\/s00044-024-03260-w.","journal-title":"Med Chem Res"},{"key":"1059_CR110","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.conctc.2018.08.001","volume":"11","author":"DB Fogel","year":"2018","unstructured":"Fogel DB. Factors Associated With Clinical Trials That Fail and Opportunities for Improving the Likelihood of Success: A review. Contemp Clin Trials Commun. 2018;11:156\u201364. https:\/\/doi.org\/10.1016\/j.conctc.2018.08.001.","journal-title":"Contemp Clin Trials Commun"},{"issue":"3","key":"1059_CR111","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood\u2013Brain Barrier Breakdown in Alzheimer Disease and Other Neurodegenerative Disorders. Nat Rev Neurol. 2018;14(3):133\u201350. https:\/\/doi.org\/10.1038\/nrneurol.2017.188.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"1059_CR112","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1113\/ep086434","volume":"103","author":"A Setiadi","year":"2018","unstructured":"Setiadi A, Korim WS, Elsaafien K, Yao ST. The Role of the Blood-brain Barrier in Hypertension. Exp Physiol. 2018;103(3):337\u201342. https:\/\/doi.org\/10.1113\/ep086434.","journal-title":"Exp Physiol"},{"issue":"11","key":"1059_CR113","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1161\/strokeaha.110.608257","volume":"42","author":"Y Yang","year":"2011","unstructured":"Yang Y, Rosenberg GA. Blood-Brain Barrier Breakdown in Acute and Chronic Cerebrovascular Disease. Stroke. 2011;42(11):3323\u20138. https:\/\/doi.org\/10.1161\/strokeaha.110.608257.","journal-title":"Stroke"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01059-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-025-01059-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01059-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:12:40Z","timestamp":1745817160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-025-01059-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":113,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1208\/s12248-025-01059-0","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"16 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"73"}}